{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["colloidal gold labeling", "hepatitis C virus", "rapid tests", "streptavidin fusion proteins"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30350885", "DateCompleted": {"Year": "2019", "Month": "04", "Day": "29"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "23"}], "Language": ["eng"], "ELocationID": ["e22701", "10.1002/jcla.22701"], "Journal": {"ISSN": "1098-2825", "JournalIssue": {"Volume": "33", "Issue": "3", "PubDate": {"Year": "2019", "Month": "Mar"}}, "Title": "Journal of clinical laboratory analysis", "ISOAbbreviation": "J Clin Lab Anal"}, "ArticleTitle": "Recombinant streptavidin fusion proteins as signal reporters in rapid test of human hepatitis C virus infection.", "Pagination": {"StartPage": "e22701", "MedlinePgn": "e22701"}, "Abstract": {"AbstractText": ["Early diagnosis of hepatitis C virus (HCV) infection is very important for the treatment of the disease. Development of sensitive and specific rapid detection assays is of great significance for the diagnosis. Here, we describe a promising method of using gold-labeled streptavidin fusion proteins as novel signal reporter in a rapid detection assay for HCV infection.", "Recombinant genes encoding streptavidin fused with Escherichia coli maltose-binding protein (MBP) or with a portion of bacterial translational initiation factor 2 were cloned in expression vectors pMAL-5CX and pET28 and transformed in proper Escherichia coli host strains. The genes were induced and streptavidin fusion proteins, named M-STV and IF-STV, respectively, were purified by affinity chromatography to over 90% purity. The biotin-binding activity of M-STV and IF-STV was tested by enzyme-linked immunosorbent assay (ELISA). M-STV was labeled with colloidal gold nanoparticles and used as a signal reporter to develop a lateral flow-based rapid test for detecting anti-HCV antibodies in human blood samples.", "M-STV showed slightly higher biotin-binding activity and similar binding specificity as compared to commercial streptavidin. The gold-labeled M-STV bound specifically to biotin moieties immobilized on the rapid test strips in a dose-responsive manner and was successfully used in detecting HCV antibodies in serum samples of patients infected with HCV. The rapid test displayed higher detection sensitivity than gold-labeled commercial NeutrAvidin.", "Our results indicate that gold-labeled M-STV is a promising agent in rapid tests of HCV infection and possibly other viral infections."], "CopyrightInformation": "\u00a9 2018 Wiley Periodicals, Inc."}, "AuthorList": [{"Identifier": ["0000-0003-2124-7988"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}, {"Identifier": [], "Affiliation": "Jiangsu Key Laboratory of Marine Biotechnology, Huaihai Institute of Technology, Lianyungang, China."}], "LastName": "Zhou", "ForeName": "Shengliang", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Cao", "ForeName": "Shinian", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Xuzhou Comprehensive Center for Inspection and Testing of Quality and Technical Supervision, Xuzhou, China."}], "LastName": "Ma", "ForeName": "Guoliang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Lingxin Biosciences Ltd., Xuzhou, China."}], "LastName": "Ding", "ForeName": "Tielin", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Mu", "ForeName": "Jingjing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Han", "ForeName": "Weilu", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}, {"Identifier": [], "Affiliation": "Lingxin Biosciences Ltd., Xuzhou, China."}], "LastName": "Sun", "ForeName": "Dongxu", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Biotechnology for Medicinal Plants of Jiangsu Province, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Chen", "ForeName": "Caifa", "Initials": "C"}], "DataBankList": [{"DataBankName": "GENBANK", "AccessionNumberList": ["X03591"]}], "GrantList": [{"GrantID": "15KJA180002", "Agency": "Major Projects of Natural Science Foundation of the Jiangsu Higher Education Institutions of China", "Country": ""}, {"GrantID": "2015HS003", "Agency": "the Open-end Funds of Jiangsu Key Laboratory of Marine Biotechnology, Huaihai Institute of Technology", "Country": ""}, {"GrantID": "31300067", "Agency": "National Nature Science Foundation of China", "Country": ""}, {"GrantID": "KC17141", "Agency": "Science and Technology Project of Xuzhou", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Clin Lab Anal", "NlmUniqueID": "8801384", "ISSNLinking": "0887-8013"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Escherichia coli Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Gold Colloid"}, {"RegistryNumber": "0", "NameOfSubstance": "Hepatitis Antibodies"}, {"RegistryNumber": "0", "NameOfSubstance": "MalE protein, E coli"}, {"RegistryNumber": "0", "NameOfSubstance": "Periplasmic Binding Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Recombinant Fusion Proteins"}, {"RegistryNumber": "9013-20-1", "NameOfSubstance": "Streptavidin"}], "MeshHeadingList": [{"QualifierName": ["methods"], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": ["chemistry", "genetics", "metabolism"], "DescriptorName": "Escherichia coli Proteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Gold Colloid"}, {"QualifierName": ["blood"], "DescriptorName": "Hepatitis Antibodies"}, {"QualifierName": ["diagnosis"], "DescriptorName": "Hepatitis C"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "genetics", "metabolism"], "DescriptorName": "Periplasmic Binding Proteins"}, {"QualifierName": ["chemistry", "genetics", "metabolism"], "DescriptorName": "Recombinant Fusion Proteins"}, {"QualifierName": ["chemistry", "genetics", "metabolism"], "DescriptorName": "Streptavidin"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Armstrong GL, Wasley A, Simard EP, McQuilan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144:705\u2010715.", "ArticleIdList": ["16702586"]}, {"Citation": "Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29:74\u201081.", "ArticleIdList": ["19207969"]}, {"Citation": "Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age\u2010specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u20101342.", "ArticleIdList": ["23172780"]}, {"Citation": "Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17:107\u2010115.", "ArticleIdList": ["21091831"]}, {"Citation": "Xia G, Liu C, Cao H, et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross\u2010sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992. Int Hepatol Commun. 1996;5(1):62\u201073."}, {"Citation": "Westbrook RH, Dusheiko G. Natural history of hepatitis C. J Hepatol. 2014;61:S58\u2010S68.", "ArticleIdList": ["25443346"]}, {"Citation": "Duan Z, Jia JD, Hou J, et al. Current challenges and the management of chronic hepatitis C in mainland China. J Clin Gastroenterol. 2014;48(8):679\u2010686.", "ArticleIdList": ["PMC4162325", "24921215"]}, {"Citation": "Cheng T, Zhang XL, Hu JJ, Li B, Wang Q. The role of routine screening in blood\u2010borne pathogens in Chinese patients undergoing joint arthroplasty. Bone Joint Res. 2017;6(9):566\u2010571.", "ArticleIdList": ["PMC5630999", "28963103"]}, {"Citation": "Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection\u2010a systematic review. JAMA. 2007;297(7):724\u2010732.", "ArticleIdList": ["17312292"]}, {"Citation": "Kwiatkowski CF, Fortuin Corsi K, Booth RE. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction. 2002;97(10):1289\u20101294.", "ArticleIdList": ["12359033"]}, {"Citation": "Desbois D, Vaghefi P, Savary J, Dussaix E, Roque\u2010Afonso A\u2010M. Sensitivity of a rapid immuno\u2010chromatographic test for Hepatitis C antibodies detection. J Clin Virol. 2008;41:129\u2010133.", "ArticleIdList": ["18069058"]}, {"Citation": "Lee SR, Yearwood GD, Guillon GB, et al. Evaluation of a rapid, point\u2010of\u2010care test device for the diagnosis of hepatitis C infection. J Clin Virol. 2010;48:15\u201017.", "ArticleIdList": ["20362493"]}, {"Citation": "Aghemo A, Colombo M. A rapid point\u2010of\u2010care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations? Gastroenterology. 2011;140:1347\u20101349.", "ArticleIdList": ["21354169"]}, {"Citation": "Parisi MR, Soldini L, Vidoni G, et al. Point\u2010of\u2010care testing for HCV infection: recent advances and implications for alternative screening. New Microbiol. 2014;37:449\u2010457.", "ArticleIdList": ["25387283"]}, {"Citation": "Diamandis EP, Christopoulos TK. The biotin\u2010(strept)avidin system: Principles and applications in biotechnology. Clin Chem. 1991;37:625\u2010636.", "ArticleIdList": ["2032315"]}, {"Citation": "Lindqvist Y, Schneider G. Protein\u2010biotin interactions. Curr Opin Struct Biol. 1996;6:798\u2010803.", "ArticleIdList": ["8994880"]}, {"Citation": "Hiller Y, Gershoni JM, Bayer EA, Wilchek M. Biotin binding to avidin. Oligosaccharide side chain not required for ligand association. Biochem J. 1987;248:167\u2010171.", "ArticleIdList": ["PMC1148514", "3435435"]}, {"Citation": "Wang Y, Ping J, Ye Z, Wu J, Ying Y. Impedimetric immunosensor based on gold nanoparticles modified graphene paper for label\u2010free detection of Escherichia coli O157:H7. Biosens Bioelectron. 2013;49:492\u2010498.", "ArticleIdList": ["23811484"]}, {"Citation": "Guo Z, Duan J, Yang F, et al. A test strip platform based on DNA\u2010functionalized gold nanoparticles for on\u2010site detection of mercury (II) ions. Talanta. 2012;93:49\u201054.", "ArticleIdList": ["22483875"]}, {"Citation": "Uluda\u011f Y, Hammond R, Cooper MA. A signal amplification assay for HSV type 1 viral DNA detection using nanoparticles and direct acoustic profiling. J Nanobiotechnol. 2010;8:3."}, {"Citation": "Argarana CE, Kuntz ID, Birken S, Axel R, Cantor CR. Molecular cloning and nucleotide sequence of the streptavidin gene. Nucleic Acids Res. 1986;14:1871\u20101882.", "ArticleIdList": ["PMC339579", "3951999"]}, {"Citation": "Chiao DJ, Shyu RH, Hu CS, Chiang HY, Tang SS. Colloidal gold\u2010based immunochromatographic assay for detection of botulinum neurotoxin type B. J Chromatogr B. 2004;809:37\u201041.", "ArticleIdList": ["15282091"]}, {"Citation": "S\u00f8rensen HP, Sperling\u2010Petersen HU, Mortensen KK. A favorable solubility partner for the recombinant expression of streptavidin. Protein Expr Purif. 2003;32:252\u2010259.", "ArticleIdList": ["14965771"]}, {"Citation": "Marttila AT, Laitinen OH, Airenne KJ, et al. Recombinant NeutraLite avidin: a non\u2010glycosylated, acidic mutant of chicken avidin that exhibits high affinity for biotin and low non\u2010specific binding properties. FEBS Lett. 2000;467(1):31\u201036.", "ArticleIdList": ["10664451"]}, {"Citation": "Bayer EA, Meester FD, Kulik T, Wilchek M. Preparation of deglycosylated egg white avidin. Appl Biochem Biotechnol. 1995;53(1):1\u20109.", "ArticleIdList": ["7625822"]}, {"Citation": "Riggs P. Expression and purification of recombinant proteins by fusion to maltose\u2010binding protein. Mol Biotechnol. 2000;15(1):51\u201063.", "ArticleIdList": ["10911622"]}, {"Citation": "Kapust RB, Waugh DS. Escherichia coli maltose\u2010binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused. Protein Sci. 1999;8(8):1668\u20101674.", "ArticleIdList": ["PMC2144417", "10452611"]}, {"Citation": "Pennati A, Deng J, Galipeau J. Maltose\u2010binding protein fusion allows for high level bacterial expression and purification of bioactive mammalian cytokine derivatives. PLoS One. 2014;9(9):e106724.", "ArticleIdList": ["PMC4157803", "25198691"]}]}], "History": [{"Year": "2018", "Month": "7", "Day": "18"}, {"Year": "2018", "Month": "9", "Day": "29"}, {"Year": "2018", "Month": "10", "Day": "1"}, {"Year": "2018", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "30", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30350885", "PMC6818559", "10.1002/jcla.22701"]}}]}